Spectinomycin

CAS 1695-77-8 4 current records 1 historicalSmall Molecule

Who holds supplier records for Spectinomycin? 4 organisations hold a current record for Spectinomycin: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Spectinomycin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/spectinomycin

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in China

    4 of the 4 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Spectinomycin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Spectinomycin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Spectinomycin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG LUKANG PHARMACEUTICAL CO., LTD. JiningCN
CEP 2015-198 - Rev 01
Spectinomycin sulfate tetrahydrate for veterinary use
Mar 2026—
HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO. LTD. Shijiazhuang CityCN
CEP 2020-069 - Rev 02
Spectinomycin sulfate tetrahydrate for veterinary use
Sept 2025—
SHANDONG QILU KING-PHAR PHARMACEUTICAL CO., LTD. PingyinCN
CEP 2016-230 - Rev 01
Spectinomycin sulfate tetrahydrate for veterinary use
Jul 2024—
ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua CityCN
CEP 2024-136 - Rev 00
Spectinomycin sulfate tetrahydrate for veterinary use, Jinxi
Jul 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Spectinomycin are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
    Inactive DMF 628 · filed Aug 1963

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Spectinomycin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1167).

Chemical identity

IUPAC name
(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one
Canonical SMILES
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O
InChIKey
UNFWWIHTNXNPBV-WXKVUWSESA-N
Synonyms
Actinospectacin, Adspec, CHX-3101, Espectinomicina, Prospec, Spectinomycin, Spectinomycine, Togamycin, Antibiotic 2233wp, Spectinomycinum, M-141, U 18409 E

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Spectinomycin?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Spectinomycin: Hebei Shengxue Dacheng Pharmaceutical Co. Ltd. (China), Shandong Lukang Pharmaceutical Co., Ltd. (China), Shandong Qilu King-phar Pharmaceutical Co., Ltd. (China) and ZHEJIANG JINHUA CONBA BIO-PHARM CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Spectinomycin records mean?

1 organisation has only inactive Type II DMFs for Spectinomycin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Spectinomycin have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Spectinomycin on the EDQM register, including SHANDONG LUKANG PHARMACEUTICAL CO., LTD. Jining (CN), HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO. LTD. Shijiazhuang City (CN), SHANDONG QILU KING-PHAR PHARMACEUTICAL CO., LTD. Pingyin (CN) and ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua City (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Spectinomycin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Spectinomycin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.